GW 0742
Alias:GW-610742; GW-0742X
Cas No: 317318-84-6
MF: C21H17F4NO3S2
MW: 471.488
Assay:99%
Appearance: White to off-white solid powder
Application:
It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease.
Reduce body fat, quickly burn fat, prevent muscle loss, known as "the king of muscle endurance supplement." A fat-burning compound suitable for shaping or strengthening muscle endurance and endogenous levels, accelerating fat breakdown, regulating body fat distribution, and reducing body recovery time.
GW-501516 is a unique drug that is officially classified as a PPAR receptor agonist (PPAR-RA) under the common trade name: Cardarine. Research on this drug began in 1992 with the joint development of GlaxoSmithKline (GSK) and Ligand Pharmaceuticals. The product was studied to provide treatment for various cardiovascular diseases as well as diabetes, obesity and other conditions, but researchers quickly discovered that PPAR-RA was very effective at improving endurance. Cardarine (GW-501516) binds to PPAR receptors, specifically a group of nuclear receptors that activate the enzyme PGC-1a (sensors that detect thyroid and steroid hormones in the body). This action results in the expression of genes, particularly those surrounding energy expenditure. Studies involving GW-501516 have shown increased fatty acid metabolism in experimental mice. In studies using monkeys, data from GW-501516 also showed an increase in HDL (good cholesterol) and a decrease in LDL (bad cholesterol), with or without exercise. GW-501516 will significantly exert its effect. The effect of GW-501516 is very significant and it is a very popular product for athletes preparing for competition. Increased muscular endurance is the most incredible effect of PPAR-RA, and those who use GW-501516 will find that their endurance is greatly improved, they will not tire easily, and they will be able to train harder. The increase in cardiovascular endurance brought about by GW-501516 is very obvious and has been shown to eliminate problems such as decreased endurance caused by the effects of the anabolic steroid trenbolone on the heart. Many people who use Trenbolone report that breathing becomes a little harder, making doing cardio a more difficult task while using Trenbolone. GW-501516 can eliminate this negative effect when using Trenbolone. . The effect of GW-501516 is also very helpful for fat loss, you can perform aerobic exercise more intensely and for a longer time. Additionally, it does not have any of the catabolic effects associated with many fat loss drugs, meaning that GW501516 will not cause muscle loss during fat loss. GW-501516 has been shown to improve nutrient utilization efficiency, making the body more responsive to food intake. The absorption and utilization rate is greatly increased. People who use GW-501516 will see increased levels of glucose uptake and decreased body fat storage.
It is currently being considered as a potential treatment for obesity by rapidly melting through what is known as fatty acid oxidation.In addition, the use of GW501516 increased HDL (good sterols) by 79% and decreased LDL (bad sterols). Estrogens: GW-501516 does not aromatize into estrogen, has no estrogenic activity itself, and has no estrogen-related side effects.
Androgens: GW-501516 has no androgenic properties, so it will not produce androgenic side effects.
Cardiovascular: GW-501516 has no negative effects on cardiovascular health; it also improves cardiovascular health, and in a study conducted by the Journal of Cardiology, GW-501516 was shown to potentially reduce the risk of heart attacks. Testosterone Suppression: GW-501516 does not inhibit natural testosterone production. Hepatotoxicity: GW-501516 is not toxic to the liver.
Advantages:
1. Significantly improves endurance and energy utilization levels, accelerating the recovery time of bone and muscle endurance
2. Rapidly melts fat and catabolizes metabolism, takes effect quickly, and can be used and stopped
3. Increases the bodys utilization of carbohydrates
4. Extremely compatible It is flexible, can be stacked on anything, and can be used when cutting or expanding.
5. No side effects, no hepatotoxicity, no inhibition, no need for PCT.
Disadvantages: As the safest product among SARMs, GW501516 will not cause any Discomfort, such as palpitation, increased heart rate, dizziness and chest tightness caused by ordinary fat-reducing supplements, will not occur. In fact, if we have to say a disadvantage, the only one is that it needs to be accompanied by aerobic exercise to achieve better results. This is different from SR9009.GW501516, which, like growth hormone, produces pro-inflammatory markers in fat tissue and reduces the activity of genes involved in lipogenesis, meaning the body is able to prevent fatty acids from being formed and stored as fat. Considering the side effects of S4, we recommend GW as the first choice for fat reduction and body shaping products, both in terms of safety and effectiveness.
Recommended use: 15-20MG daily. The use period is 8-12 weeks. Take it at a fixed time every day or before training; use it once a day.
Specifications: COA
|
Item |
Specification |
Result |
|
Appearance |
yellow powder |
Complies |
|
Related substance (HPLC) |
Total impurity ≤0.5% |
0.2% |
|
Odor |
Characteristic |
Complies |
|
Assay |
99% |
99.13% |
|
Sieve analysis |
100% pass 80 mesh |
Complies |
|
Loss on Drying |
≤1.0% |
0.12% |
|
Heavy Metal |
<10ppm |
Complies |
|
As |
<0.1ppm |
0.05ppm |
|
Pb |
<0.1ppm |
0.05ppm |
|
Cd |
<0.1ppm |
0.05ppm |
|
Residual Solvents |
<100ppm |
Complies |
|
Residual Pesticide |
Negative |
Complies |
|
Total Plate Count |
<1000cfu/g |
Complies |
|
Yeast & Mold |
<100cfu/g |
Complies |
|
E.Coli |
Negative |
Complies |
|
Salmonella |
Negative |
Complies |
